Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Bill for Healthcare Reform to Be Presented to Diet Next Year -4-
October 8, 2001
- DIAGNOSTIC NEWS IN BRIEF
October 8, 2001
- Dr Kurokawa Explains Background for Proposed PAL Amendment
October 8, 2001
- JMA, Hospital Associations Confirm Opposition to Operation of Hospitals by Private Companies
October 8, 2001
- REGULATORY NEWS IN BRIEF
October 8, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 8, 2001
- Organon Focuses on Strengthening R&D in Japan: President-elect Vemer
October 8, 2001
- OTC NEWS IN BRIEF
October 8, 2001
- European Office to Be Set Up Soon, Following US One: Mr Takusagawa of Kyorin
October 1, 2001
- DIAGNOSTIC NEWS IN BRIEF
October 1, 2001
- BULLETIN
October 1, 2001
- WORLD NEWS IN BRIEF
October 1, 2001
- Wholesalers' Gross Profit Rate Drops to Below 9%
October 1, 2001
- RIKEN to Collaborate with 14 Japanese Companies for Pharmacogenomic Research
October 1, 2001
- BUSINESS NEWS IN BRIEF
October 1, 2001
- New Results from Japan Lipid Intervention Trial Presented: Banyu
October 1, 2001
- PMSB Requires Enhanced Safety Measures Regarding Statins
October 1, 2001
- Patients' Wishes Should Be Respected in Endometriosis Treatment: Kissei Forum
October 1, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 1, 2001
- 81% of Insulin-treated Patients Experience Hypoglycemia
October 1, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…